UMIN ID: UMIN000000503
Registered date:18/10/2006
Lung Cancer Evaluation of TS-1 Study
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Previously untreated stageIIIB/IV NSCLC |
| Date of first enrollment | 2006/08/01 |
| Target sample size | 560 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | CBDCA+TS-1 chemotherapy CBDCA+Paclitaxel chemotherapy |
Outcome(s)
| Primary Outcome | Overall survival |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | 75years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | 1)SVC syndrome 2)Pregnant female or sexually active males/females unwilling to use contraception during the protocol treatment 3)Concomitant serious disease 4)Symptomatic brain metastases 5)Active concomitant malignancy 6)Pleural effusion, cardiac effusion, or cardiac effusion necessiating treatment 7)Uncontrolled diabetes |
Related Information
| Primary Sponsor | West Japan Oncology Group |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | TAIHO PHARMACEUTICAL CO.,LTD |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Shinichiro Nakamura |
| Address | Namba Plaza Bldg.3F 1-5-7,Motomachi Naniwa-ku,Osaka556-0016 JAPAN Japan |
| Telephone | 06-6633-7400 |
| datacenter@wjog.jp | |
| Affiliation | West Japan Oncology Group WJOG datacenter |
| scientific contact | |
| Name | Kazuhiko Nakagawa |
| Address | 377-2 Ohno-higashi, Osaka-Sayama, Osaka Japan |
| Telephone | 072-366-0221 |
| datacenter@wjog.jp | |
| Affiliation | Kinki University School of Medicine Department of Medical Oncology |